Rollins – Stock Analysis

On June 10, 2021, I initiated a 500 Rollins (ROL) shares position @ ~$33.15/share and explained my rationale for doing so in this Rollins stock analysis. I subsequently reviewed ROL's Q2 and YTD2021 results in my August 7th post. I now revisit ROL following the October 27th release of Q3 and YTD2021 results. Rollins - [...]

Becton Dickinson – Stock Analysis

After my August 6, 2021, Becton Dickinson (BDX) stock analysis, the company: released Q4 and FY2021 results and FY2022 guidance on November 4; and held its 2021 virtual Investor Day on November 12. Investors who invest solely based on stock price performance will view BDX to be a poor investment. Looking at BDX's shareholder return [...]

TMX Group Limited – Stock Analysis

This TMX Group Limited ( stock analysis is the final post in my series of analyses of Financial Data & Stock Exchanges industry participants. Please click here to access previous posts. NOTE: All dollar values related to X are in $CAD. I view the Financial Data & Stock Exchanges industry as an attractive industry in [...]

Viatris – Stock Analysis

In my August 10, 2021 Viatris (VTRS) stock analysis I reviewed Q2 and YTD financial results and the company's valuation based on guidance. I now revisit VTRS following the November 8, 2021 release of Q3 and YTD 2021 results and revised FY2021 guidance. Viatris - Stock Analysis - Business Overview VTRS's FY2020 Form 10-K provides [...]

Mastercard Incorporated – Stock Analysis

In my September 3, 2021 post I disclose the purchase of additional Mastercard Incorporated (MA) shares @ $340.3929/share in one of the 'Core' accounts in the FFJ Portfolio. On October 26, Visa (V) released Q4 and FY2021 results. The share price of both V and MA plunged so I acquired more shares in both companies [...]

By |November 5th, 2021|Equity Investing|Comments Off on Mastercard Incorporated – Stock Analysis

Merck & Co., Inc. – Stock Analysis

In my February 8, 2021 Merck & Co., Inc. (MRK) stock analysis I disclosed that my findings led me to initiate a 300 share position in one of the 'Core' accounts in the FFJ Portfolio. I subsequently analyzed Q1 2021 results and FY2021 guidance in my May 3, 2021 MRK stock analysis and disclosed the [...]

By |November 4th, 2021|Equity Investing|Comments Off on Merck & Co., Inc. – Stock Analysis
Go to Top